FDA Approves Botox to Treat Chronic Migraines

Botox — famous for treating wrinkles on the face — has been approved by the FDA to treat chronic migraine headaches in adults.

The FDA says Botox injections have been shown to be effective in the prevention of migraines, which are debilitating headaches that cause intense pulsing or throbbing pain and affect about 12% of Americans.

“Chronic migraine is one of the most disabling forms of headache,” Russell Katz, MD, of the FDA, says in a news release. “Patients with chronic migraine who experience a headache more than 14 days of the month. This condition can greatly affect family, work, and social life, so it is important to have a variety of effective treatment options available.”

If you or someone you know is experiencing the signs and symptoms of headache and or migraines, please schedule an appointment for a consultation with Dr. Teruel at 480-945-3629 or visit us online at www.headpaininstitute.com

News release, FDA. News release, Allergan Inc.